annual cash & cash equivalents:
$188.23M+$80.66M(+74.98%)Summary
- As of today (August 31, 2025), AGL annual cash & cash equivalents is $188.23 million, with the most recent change of +$80.66 million (+74.98%) on December 31, 2024.
- During the last 3 years, AGL annual cash & cash equivalents has fallen by -$851.81 million (-81.90%).
- AGL annual cash & cash equivalents is now -81.90% below its all-time high of $1.04 billion, reached on December 31, 2021.
Performance
AGL Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$327.00M-$41.77M(-11.33%)Summary
- As of today (August 31, 2025), AGL quarterly cash & cash equivalents is $327.00 million, with the most recent change of -$41.77 million (-11.33%) on June 30, 2025.
- Over the past year, AGL quarterly cash & cash equivalents has dropped by -$80.96 million (-19.84%).
- AGL quarterly cash & cash equivalents is now -70.95% below its all-time high of $1.13 billion, reached on June 30, 2021.
Performance
AGL quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
AGL Cash and cash equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +75.0% | -19.8% |
3 y3 years | -81.9% | -66.3% |
5 y5 years | +52.3% | - |
AGL Cash and cash equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -81.9% | +75.0% | -66.4% | at low |
5 y | 5-year | -81.9% | +76.3% | -71.0% | +173.7% |
alltime | all time | -81.9% | +76.3% | -71.0% | +173.7% |
AGL Cash and cash equivalents History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $327.00M(-11.3%) |
Mar 2025 | - | $368.77M(-9.1%) |
Dec 2024 | $188.23M(+75.0%) | $405.60M(+1.8%) |
Sep 2024 | - | $398.56M(-2.3%) |
Jun 2024 | - | $407.96M(-4.2%) |
Mar 2024 | - | $425.91M(-14.0%) |
Dec 2023 | $107.57M(-76.9%) | $495.10M(-13.8%) |
Sep 2023 | - | $574.42M(-2.7%) |
Jun 2023 | - | $590.23M(-28.6%) |
Mar 2023 | - | $826.89M(-6.9%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2022 | $465.30M(-55.3%) | $887.81M(-8.7%) |
Sep 2022 | - | $972.47M(+0.3%) |
Jun 2022 | - | $969.25M(-6.5%) |
Mar 2022 | - | $1.04B(-1.8%) |
Dec 2021 | $1.04B(+873.9%) | $1.05B(-3.7%) |
Sep 2021 | - | $1.10B(-2.6%) |
Jun 2021 | - | $1.13B(+842.1%) |
Mar 2021 | - | $119.49M(-11.6%) |
Dec 2020 | $106.80M(-13.6%) | $135.18M |
Dec 2019 | $123.63M | - |
FAQ
- What is agilon health, inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for agilon health, inc.?
- What is agilon health, inc. annual cash & cash equivalents year-on-year change?
- What is agilon health, inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for agilon health, inc.?
- What is agilon health, inc. quarterly cash & cash equivalents year-on-year change?
What is agilon health, inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of AGL is $188.23M
What is the all time high annual cash & cash equivalents for agilon health, inc.?
agilon health, inc. all-time high annual cash & cash equivalents is $1.04B
What is agilon health, inc. annual cash & cash equivalents year-on-year change?
Over the past year, AGL annual cash & cash equivalents has changed by +$80.66M (+74.98%)
What is agilon health, inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of AGL is $327.00M
What is the all time high quarterly cash & cash equivalents for agilon health, inc.?
agilon health, inc. all-time high quarterly cash & cash equivalents is $1.13B
What is agilon health, inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, AGL quarterly cash & cash equivalents has changed by -$80.96M (-19.84%)